Tina Morrison

Dr. Morrison is currently directs the Office of Regulatory Science and Innovation in the Office of the Chief Scientist at the FDA. She joined the FDA in 2008 through the Medical Device Fellowship Program. For the first 7 years, Tina was a regulatory reviewer of cardiovascular devices, where she participated in several initiatives as part of CDRH’s Innovation Pathway: early feasibility studies program, streamlining clinical trials, the medical device development tools program, and the Medical Device Innovation Consortium. Alongside the regulatory review work, she was also worked to advance the role of computer modeling and simulation in medical device design and product evaluation. She joined the Office of Science and Engineering.